These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28267963)

  • 1. Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Webb J; Villa A; Bekri I; Shome J; Teall T; Claridge S; Jackson T; Porter B; Ismail TF; Di Giovine G; Rinaldi CA; Carr-White G; Al-Fakih K; Razavi R; Chiribiri A
    Am J Cardiol; 2017 May; 119(9):1450-1455. PubMed ID: 28267963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.
    Bois JP; Geske JB; Foley TA; Ommen SR; Pellikka PA
    Am J Cardiol; 2017 Feb; 119(4):643-650. PubMed ID: 27956002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy.
    Hindieh W; Weissler-Snir A; Hammer H; Adler A; Rakowski H; Chan RH
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Magnetic Resonance Imaging Features in Hypertrophic Cardiomyopathy Diagnosed at <21 Years of Age.
    Bonura ED; Bos JM; Abdelsalam MA; Araoz PA; Ommen SR; Ackerman MJ; Geske JB
    Am J Cardiol; 2020 Apr; 125(8):1249-1255. PubMed ID: 32088002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden cardiac death risk in hypertrophic cardiomyopathy: comparison between echocardiography and magnetic resonance imaging.
    Śpiewak M; Kłopotowski M; Kowalik E; Kubik A; Ojrzyńska-Witek N; Petryka-Mazurkiewicz J; Michalak E; Mazurkiewicz Ł; Gawor M; Kożuch K; Miłosz-Wieczorek B; Grzybowski J; Bilińska Z; Witkowski A; Klisiewicz A; Marczak M
    Sci Rep; 2021 Mar; 11(1):7146. PubMed ID: 33785804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of left ventricular mass in hypertrophic cardiomyopathy by real-time three-dimensional echocardiography using single-beat capture image.
    Chang SA; Kim HK; Lee SC; Kim EY; Hahm SH; Kwon OM; Park SW; Choe YH; Oh JK
    J Am Soc Echocardiogr; 2013 Apr; 26(4):436-42. PubMed ID: 23363779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Ventricular Septal Measurements in Hypertrophic Cardiomyopathy Patients Who Underwent Surgical Myectomy Using Multimodality Imaging and Implications for Diagnosis and Management.
    Phelan D; Sperry BW; Thavendiranathan P; Collier P; Popović ZB; Lever HM; Smedira NG; Desai MY
    Am J Cardiol; 2017 May; 119(10):1656-1662. PubMed ID: 28363351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-Enhanced Echocardiographic Measurement of Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy: Comparison with Standard Echocardiography and Cardiac Magnetic Resonance.
    Urbano-Moral JA; Gonzalez-Gonzalez AM; Maldonado G; Gutierrez-Garcia-Moreno L; Vivancos-Delgado R; De Mora-Martin M; Rodriguez-Palomares JF; Evangelista-Masip A
    J Am Soc Echocardiogr; 2020 Sep; 33(9):1106-1115. PubMed ID: 32564979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy.
    Olivotto I; Gistri R; Petrone P; Pedemonte E; Vargiu D; Cecchi F
    J Am Coll Cardiol; 2003 Jan; 41(2):315-21. PubMed ID: 12535828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helical distribution of hypertrophy in patients with hypertrophic cardiomyopathy: prevalence and clinical implications.
    Viliani D; Pozo E; Aguirre N; Cecconi A; Olivera MJ; Caballero P; Jiménez-Borreguero LJ; Alfonso F
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1771-1780. PubMed ID: 28536896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients.
    Riza Demir A; Celik Ö; Sevinç S; Uygur B; Kahraman S; Yilmaz E; Cemek M; Onal Y; Erturk M
    Ann Noninvasive Electrocardiol; 2019 Sep; 24(5):e12672. PubMed ID: 31152489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spirito-Maron echocardiographic score: a marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy.
    Rangel I; Gonçalves A; de Sousa C; Correia AS; Pinho T; Madureira AJ; Martins E; Cardoso JS; Macedo F; Maciel MJ
    Echocardiography; 2014 Jul; 31(6):708-15. PubMed ID: 24460546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of right ventricular function and size in patients with hypertrophic cardiomyopathy.
    Śpiewak M; Kłopotowski M; Mazurkiewicz Ł; Kowalik E; Petryka-Mazurkiewicz J; Miłosz-Wieczorek B; Klisiewicz A; Witkowski A; Marczak M
    Sci Rep; 2020 Dec; 10(1):21054. PubMed ID: 33273702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
    Rickers C; Wilke NM; Jerosch-Herold M; Casey SA; Panse P; Panse N; Weil J; Zenovich AG; Maron BJ
    Circulation; 2005 Aug; 112(6):855-61. PubMed ID: 16087809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.
    Avegliano GP; Costabel JP; Asch FM; Sciancalepore A; Kuschnir P; Huguet M; Tobon-Gomez C; Frangi AF; Ronderos R
    Echocardiography; 2016 Mar; 33(3):431-6. PubMed ID: 26525462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the left ventricular anatomy in hypertrophic cardiomyopathy: comparison between echocardiography and cardiac magnetic resonance imaging.
    Romano R; Losi MA; Migliore T; Contaldi C; Parrella LS; Caputi A; Betocchi S
    Minerva Cardioangiol; 2008 Apr; 56(2):181-7. PubMed ID: 18319696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study.
    Greulich S; Seitz A; Herter D; Günther F; Probst S; Bekeredjian R; Gawaz M; Sechtem U; Mahrholdt H
    Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):732-741. PubMed ID: 33458753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
    Valente AM; Lakdawala NK; Powell AJ; Evans SP; Cirino AL; Orav EJ; MacRae CA; Colan SD; Ho CY
    Circ Cardiovasc Genet; 2013 Jun; 6(3):230-7. PubMed ID: 23690394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.